Company Filing History:
Years Active: 1989
Title: The Innovations of Toshiyuki Kamayama
Introduction
Toshiyuki Kamayama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of microbiology and anti-tumor research. His work has led to the development of a novel compound with promising therapeutic applications.
Latest Patents
Kamayama holds a patent for Bisucaberin, a compound recognized for its anti-tumor activity. This compound, scientifically described as 1,12-dihydroxy-1,6,12,17-tetraazacyclodocosan-2,5,13,16-tetrone, is produced microbiologically by culturing a microorganism from the genus Alteromonas, specifically Alteromonas haloplanktis SB-1123. The patent details the characterization of the compound and the microbiological properties of the microorganism. In vitro assays have demonstrated the anti-tumor efficacy of Bisucaberin against L-1210 and IMC carcinoma cells.
Career Highlights
Kamayama is affiliated with the Microbial Chemistry Research Foundation, where he continues to explore innovative solutions in microbiology. His research focuses on harnessing microbial properties for therapeutic advancements.
Collaborations
Kamayama has collaborated with notable colleagues, including Yoshiro Okami and Shogo Kurasawa, to further his research endeavors.
Conclusion
Toshiyuki Kamayama's work exemplifies the intersection of microbiology and cancer research, showcasing the potential of novel compounds in therapeutic applications. His contributions continue to inspire advancements in the field.